Medifast Inc reports results for the quarter ended June 30 - Earnings Summary

Medifast

03/08/2026 22:02

Medifast Inc MED.N reported a quarterly adjusted loss of 28 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 22 cents.  The lone analyst forecast for the quarter was for a loss of 65 cents per share. 
Revenue fell 27.6% to $76.38 million from a year ago; analysts expected $72.70 million. 
Medifast Inc's reported EPS for the quarter was a loss of 28 cents​.
The company reported a quarterly loss of $3.1 million.
Medifast Inc shares had fallen by 7.4% this quarter and lost 8.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 51.2% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the food processing peer group is  "buy."
Wall Street's median 12-month price target for Medifast Inc is $12.00, about 18.1% above its last closing price of $9.83
This summary was machine generated from LSEG data August 3 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.65
-0.28
Beat
Mar. 31 2026 
-0.52
-0.19
Beat
Dec. 31 2025 
-0.82
-1.65
Missed
Sep. 30 2025 
-0.39
-0.21
Beat